Related Experiment Video
Updated: Feb 22, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the Tree
Paulo Bergerot1, Neeraj Agarwal2, Sumanta K Pal1
1Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
This study shows sarcomatoid renal cell carcinoma (sRCC) is linked to the epithelial cancer component. It also suggests sRCC may not evolve from low-grade kidney cancer and points to new differentiation mediators.
Area of Science:
- Oncology
- Genomics
- Cancer Biology
Background:
- Sarcomatoid renal cell carcinoma (sRCC) is an aggressive subtype of kidney cancer.
- The relationship between the sarcomatoid and epithelial components of sRCC is not fully understood.
- The evolutionary origin of sRCC, particularly its potential development from low-grade renal cell carcinoma (RCC), remains debated.
Purpose of the Study:
- To perform comprehensive genomic sequencing of sRCC.
- To investigate the relationship between the sarcomatoid and epithelial components of sRCC.
- To identify potential genetic drivers of sarcomatoid differentiation and challenge existing theories on sRCC evolution.
Main Methods:
- Whole-exome sequencing of matched tumor samples from sRCC patients.
- Comparative genomic analysis between sarcomatoid and epithelial components.
- Bioinformatic analysis to identify key mutations and pathways involved in sarcomatoid differentiation.
Main Results:
- The study provides the most comprehensive genomic data for sRCC to date.
- Genomic analysis reinforces the close relationship between the sarcomatoid and epithelial cancer components.
- Findings challenge the hypothesis that sRCC commonly evolves from low-grade RCC.
- Potential mediators and pathways driving sarcomatoid differentiation were identified.
Conclusions:
- The sarcomatoid component of sRCC is intrinsically linked to its epithelial counterpart.
- The evolutionary trajectory of sRCC may differ from current hypotheses, not always arising from low-grade precursors.
- Identification of potential mediators opens new avenues for understanding and targeting sarcomatoid differentiation in kidney cancer.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation